Chandigarh

Financial BO

Goods

Medicines

Inj Human Antihaemophillic Factor VIII High Purity 1000 IU

Government Medical College and Hospital

GMCH-32 | Chandigarh

Amount: Refer DocsCloses: 23 Jun 2020Closed

Timeline

Published17 Mar 2020
Closed23 Jun 2020
Technical Evaluation21 Jul 2020
Financial Evaluation27 Jul 2020
Award—

Bids

2 Bids27 Jul 2020

#	Company	Status
1	BAXALTA BIOSCIENCE INDIA PVT LTD Admitted-Finance	Admitted-Finance
2	Novo Nordisk India Private Limited Admitted-Finance 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 \| BANGALORE \| BANGALORE \| KARNATAKA \| 560045	Admitted-Finance

Tender Value

Refer Docs

EMD Value

₹2.3 L

Closing Date

23 Jun 2020, 2:00 pmClosed

Tender Inviting Organisation

Name

Director Principal

Address

Director Principal, GMCH-32, Chandigarh

Work Description

Inj Human Antihaemophillic Factor VIII High Purity 1000 IU

Tender Information

Tender ID

2020_GMCH_54393_1

Reference Number

GMCH-PH-PRO-Med 528/2020

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Rate

Period of Work

40 days

Location

GMCH-32

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer Tender documents.

Documents Required

12 documents required · 12 mandatory

Fee

Requiredfinance (.pdf)

PreQual/Technical

RequiredComplete specification with packing detail need to be mentioned by supplier. (.pdf)

RequiredManufacturing License from Principal Manufacturer (.pdf)

RequiredGMP Certificate under Schedule M/revised Schedule M of Drug Cosmetic Act or WHOGMP from manufacturer (.pdf)

RequiredIf rates are quoted by the distributor/sister concern/ dealer then authority letter should be submit (.pdf)

RequiredAffidavit in prescribed performa regarding non-blacklisting of firm from Principal Manufacturer. (.pdf)

RequiredList of buyers to whom you have supplied drug (min 100 bedded hospitals) from Principal Manufacturer (.pdf)

RequiredNo.of yrs standing of firm in drug manufacturing sector(required min3yrs)from Principal manufacturer (.pdf)

RequiredUndertaking to be submitted that no mishap has been reported from any of item manufactured by firm. (.pdf)

RequiredAnnual turn over of min last 3 yrs duly certified by C.A. (min 1 crore) from Principal manufacturer. (.pdf)

RequiredValidity of rates and rate certificate. (.pdf)

Finance

RequiredPrice Bid (.xls)

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

₹2.3 L

Important Dates

Last Activity

27 Jul 2020

Published

17 Mar 2020

Bid Opening

24 Jun 2020

Download Starts

17 Mar 2020

Download Ends

23 Jun 2020

Submission Starts

17 Mar 2020

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.02 MB

Technical Evaluation

tech_eval.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

BAXALTA BIOSCIENCE INDIA PVT LTD

Admitted-Finance

Novo Nordisk India Private Limited

Admitted-Finance

1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045